Facebook
X
LinkedIn
Forward
Nov. 6-7, 2025 - 18th Diabetes in Pregnancy Study Group - From Lab to Labor: Advancing Diabetes Care
Program Description
The 2025 "From Lab to Labor: Advancing Diabetes Care", and will feature internationally and nationally recognized experts who play an active role in a patient’s care from before conception, through the stages of pregnancy and delivery, to her long-term wellbeing.
Live Simulation Labs - LIMITED SPACE - 20 Spots Available!
Taking place on Friday, Nov. 7, 2025 from 3:00-5:30 PM at Inova Fairfax Hospital
Once you have registered for the 18th Diabetes in Pregnancy Conference, you are eligible to participate in the live simulation labs for a small additional price of $50. Information on how to register for these labs are on your conference confirmation email.
Limited spaces available to experience two separate high-fidelity endocrine obstetric emergency simulation scenarios and then debrief afterwards.
Simulation Topics:
Simulation #1: Diabetic ketoacidosis in pregnancy due to pyelonephritis
Simulation #2: Thyrotoxicosis in pregnancy
Abstract Poster Submissions - Notification Emails Have Been Sent
(https://cme.inova.org/content/nov-6-7-2025-abstract-submissions-18th-diabetes-pregnancy-study-group)
Timeline:
- Abstract submissions due: August 15, 2025.
- Abstract review deadline: September 1, 2025.
- Submitters notified of acceptance: September 15, 2025.
Accepted Submissions:
- Accepted submissions will be published in a special edition of the American Journal of Perinatology. There will also be a fast track for publication of the manuscript in AJP once the manuscript is completed.
- Authors are encouraged to submit the completed manuscript to AJP within 2 months of the conclusion of the DPSG NA meeting. All accepted submissions will be given FREE registration to attend the Nov. 6-7, 2025 DPSG-NA Conference in Fairfax, VA. Abstract posters will be presented Nov. 6, from 5:15 - 6:30 pm.
Target Audience
This event is intended for all healthcare professionals and biomedical researchers with a special interest in the treatment of pregnant women with diabetes, including:
- Basic, Translational and Clinical Research Scientists
- Diabetes Educators
- Endocrinologists
- Family Practitioners
- Fellows
- Gynecologists
- Internists
- Maternal-Fetal Medicine Subspecialists
- Midwives
- Neonatologists
- Nurses and Nurse Practitioners
- Obstetricians
- Physicians’ Assistants
- Nutritionists
- Residents
- Students
Learning Objectives
- Assess the effects of insulin dependent diabetes on long term health on the offspring
- Compare novel therapies in the management of GDM and type 2 diabetes in pregnancy
- Analyze the effect that technological innovations, specifically AI, have on the management of diabetes in pregnancy
- Understand the importance of comprehensive nutritional strategies beyond carb counting in managing diabetes during pregnancy, and explore key dietary considerations to support optimal maternal and fetal health.
- Examine the impact of social determinants of health on diabetes management and outcomes, and explore strategies to address these factors in improving care for individuals with diabetes.
History of Diabetes in Pregnancy Study Group of Northern America (DPSG-NA)
DPSG-NA was founded in 1997 by a small group of Maternal-Fetal Medicine specialists with a distinct interest in diabetes in pregnancy. Since its inception, the DPSG-NA meetings have become a vehicle for the dissemination of data, gathered through collaboration among basic, translational and clinical researchers and care centers.
Only through a collaborative, multi-faceted approach can we ever hope to overcome the health burden and devastation that pregnancies complicated by diabetes can bring to a family by:
Bringing together healthcare experts and those still in training to learn about and discuss the major and timely issues related to diabetes in pregnancy.
Providing a highly interactive forum for exploring new approaches to prevention, management and treatment of diabetes in pregnancy to improve outcomes of pregnancies complicated by type 1, type 2, and gestational diabetes mellitus, and other cardiometabolic health risk factors.
Promoting collaboration and initiation of new research in diabetes in pregnancy.
Promoting Safety, Respect, and Inclusion for All Learners
The organizers of the Diabetes in Pregnancy Study Group Conference are committed to fostering a safe, respectful, and inclusive environment for all attendees. Harassment of any kind—including but not limited to sexual, racial, ethnic, or other discriminatory behavior—will not be tolerated. All participants are expected to engage in professional conduct and treat others with dignity and respect. Attendees will receive clear instructions on how to confidentially report any violations to designated conference organizers, who will promptly assess all allegations and take appropriate action, which may include removal from the event. Information on how to file a complaint with the conference organizers (Christina Fontana & Scott Sullivan at INOVA Fairfax) will be provided, along with clarification that reporting to the conference organizers is not a prerequisite for filing with HHS OCR. Additionally, attendees will be informed of how to notify NIH of any concerns related to harassment or inappropriate conduct. The safety plan will be communicated in advance via email, included in the conference program, and posted prominently at the venue. All reports and actions taken will be documented to ensure accountability and transparency.
Questions & Refunds
Refunds will be allowed up to seven days before the event, November 1, 2025. Refund requests need to be submitted in writing to [email protected].
If at any time you have questions, please email: [email protected]
Day 1 – November 6, 2025
7:00 AM - Registration & Breakfast with Exhibitors in Atrium
7:30 AM - Welcome
Speakers: Scott Sullivan, MD & Sarah Crimmins, DO
7:40 AM - Tribute to Menachem Miodovnik, MD
Speaker: E. Albert Reece, MD, PhD, MBA
Session I: Menachem's Collaborative Research Legacy: Scripting Intergenerational Health
Moderators: Jane C. Khoury, PhD & Christine Wey Hockett, PhD
8:05 AM - COMPASS-P: Navigating Diabetes in Pregnancy Through Six Critical Phases
Speakers: Barak Rosenn, MD & Jane C. Khoury, PhD
8:30 AM - Developmental Origins of Metabolic Dysfunction: Long-Term Consequences of Intrauterine Exposure to Maternal Diabetes
Speaker: Katherine A. Bowers, PhD, MPH
8:55 AM - Perinatal Adiposity as a Pathway Linking Trimester-specific Hyperglycemia in IDDM Women to Offspring Obesity in Adulthood
Speaker: Ketrell L. McWhorter, PhD, MBA
9:20 AM - Hearts and Kidneys at Risk: Long-Term Cardiovascular and Renal Consequences of Fetal Exposure to Maternal Diabetes
Speaker: Shelley R. Ehrlich, MD, ScD, MPH
9:50 AM - Q&A
10:10 AM - Break with Exhibitors in Atrium
Session II: Pregnancy in the Age of AI: Tackling Diabetes with Genomics and Innovation
Moderators: Barak Rosenn, MD & Ellen Murrin, DO
10:15 AM - From Genes to Gestation: Latest Discoveries in Diabetes and Pregnancy
Speaker: Huda Al-Kouatly, MD
10:35 AM - From Steel Magnolias to Smart Tech: Revolutionizing Diabetes Care in Pregnancy
Speaker: Karl Seif, MD
10:55 AM - CGM and GDM and T2DM
Speaker: Rana Malek, MD
11:15 AM - Off Label use of Hybrid Closed Loop Therapy for Pregnancies Complicated by Diabetes
Speaker: Camille E. Powe, MD
11:35 AM - Anytime, Anywhere MFM: Transforming Diabetic Pregnancy Care Through Telemedicine
Speaker: Sina Haeri, MD
11:55 AM - Q&A
12:00 PM - Lunch - Visit with Exhibitors & View Posters in Atrium
Session III: Diabetes and the Placenta: From Microscope to Maternal Health
Moderators: Leslie Myatt, PhD & Yoel Sadovsky, MD
1:00 PM - Sexual Dimorphism in Placental Function with Maternal Obesity and GDM
Speaker: Leslie Myatt, PhD
1:25 PM - Placental O-GlcNAc Transferase: The X Factor in Gestational Diabetes
Speaker: Stephanie Olivier-Van Stichelen, PhD
1:50 PM - Small Cargo Within Nano-packages for Pregnancy Health
Speaker: Yoel Sadovsky, MD
2:15 PM - Q&A
Session IV: Balancing Tradition and Innovation in GDM and Type 2 Management in Pregnancy
2:25 PM - Medications in Management: Balancing Safety, Efficacy, and Patient Convenience in GDM and Type 2 DM
Moderator: Sarah Crimmins, DO
Insulin as the Gold Standard: Optimizing Safety and Efficacy in GDM and Type 2 Diabetes Management
Speaker: Maisa N. Feghali, MD, MS
Oral Hypoglycemics: A Modern Approach to Balancing Efficacy and Patient Convenience in GDM and Type 2 Diabetes Treatment
Speaker: Anna Palatnik, MD
3:25 PM - Break with Exhibitors in Atrium
Session V: Cutting-Edge Imaging in the Gravida: A Visual Journey
Moderators: Shifa Turan, MD & Jacques Abramowicz, MD
3:40 PM - 3D Assessment of Fetal Body Composition in Gestational Diabetes and Glucose Intolerance
Speaker: Katherine Laughon Grantz, MD, MS
4:00 PM - Ultrasound Insights: A Window into Diabetic Pregnancy Complications
Speaker: Jacques Abramowicz, MD
4:20 PM - Artificial Intelligence in Perinatal Diagnosis and Management of Congenital Heart Disease
Speaker: Shifa Turan, MD
4:40 PM - Universal Early Cardiac Screening in Diabetic Pregnancy: A Cost-Benefit Analysis
Speaker: Alfred Z. Abuhamad, MD (virtual)
5:00 PM - Q&A
5:30 PM - Reception with Abstract Poster Presentations in Atrium
Day 2 – November 7, 2025
7:00 AM - Registration & Breakfast with Exhibitors in Atrium
7:30 AM - Welcome and Introductions
Moderators: E. Albert Reece, MD, PhD, MBA & Mark Landon, MD
Lifetime Achievement Awards
7:50 AM - Keynote Address: In Honor of Menachem Miodovnik
Lecture: Mitigating Diabetes Complications: Bench to Bedside Paradigm
Speaker: E. Albert Reece, MD, PhD, MBA
Session VI: Diabetes and Pregnancy: Priorities and Funding Opportunities
Moderators: E. Albert Reece, MD, PhD, MBA & Mark Landon, MD
8:25 AM - Perspectives from the March of Dimes
Speaker: Michael Warren, MD, MPH
8:55 AM - Perspectives from PCORI
Speaker: Denise Bonds, MD
9:25 AM - Perspective from Burroughs Welcome Funds
Speaker: Louis Muglia, MD, PhD
9:55 AM - Q&A
10:10 AM - Break with Exhibitors in Atrium
Session VII: Beyond Carb Counting: Unlocking Optimal Nutrition in Diabetic Pregnancy
Moderators: Anna Palatnik, MD & Patrick Catalano, MD
10:25 AM - Redefining Diabetes Nutrition in Pregnancy: Beyond the 2000-Calorie Myth
Speaker: Patrick Catalano, MD
10:45 AM - Eating for Two with Diabetes in Pregnancy: Modern Dietary Strategies- New Guidelines for Optimal Health
Speaker: Amy Valent, DO
11:05 AM - From Restriction to Balance: Challenging Traditional Diets for Diabetes in Pregnancy Re-examining Carbohydrate Requirements
Speaker: Terry Hernandez, PhD, RN
11:35 AM - Ultra-Processed Food Intake and Risk for Gestational Diabetes
Speaker: Cuilin Zhang, MD, PhD, MPH (virtual)
11:55 PM - Q&A
12:05 PM - Lunch with Exhibitors and “Ask the Expert” in Atrium
Session VIII: Shaping Tomorrow's Care: Early Career Investigators at the Frontier of Diabetes in Pregnancy Research
Moderators: Monica Longo, MD & Anna Palatnik, MD
1:15 PM - Setting the Bar: Evidence-Based Glycemic Targets to Optimize Pregnancy Outcomes in Women with Diabetes
Speaker: Ashley Battarbee, MD
1:35 PM - Islet Cell Dynamics in Gestational Diabetes: From Pregnancy to Postpartum
Speaker: Aoife Maria Egan, MD, MBBCh, PhD
1:55 PM - Maternal Hyperglycemia and Cardiac Development: Induced Pluripotent Stem Cell Insights
Speaker: Javier Contreras, BS
2:15 PM - The Geography of Gestation: Diabetes and the Role of Community
Speaker: Kartik Ventakesh, MD, PhD (virtual)
2:35 PM - Q&A
2:45 PM - Break
Session IX: Breakout Sessions
Breakout A: Simulation (Pre-registration is Required - $50 per person)
Moderators: Shad Deering, MD & Antonio Saad, MD
Simulation | Faculty Planner | Location | Max participants |
DKA in pregnancy | Shad Deering, MD | Inova Fairfax Hospital | 10 |
Thyroid Storm | Shad Deering, MD | Inova Fairfax Hospital | 10 |
Breakout B: Social Determinants of Health and Diabetes
Moderator: Christine Field, MD, MPH
3:10 PM - Cultural Awareness and Grounded Diabetes Care for Latina Individuals
Speaker: Gladys "Sandy" Ramos, MD
3:30 PM - Group Prenatal Care in Minoritized Individual Living with Diabetes
Speaker: Ebony B. Carter, MD, MPH
4:00 PM - Upstream Interventions: Preventing T2DM Disparities After GDM
Speaker: Teresa Janevic, PhD, MPH
4:25 PM - Tailoring Diabetes Care: Ancestry-Informed Strategies for Prediabetes, GDM, and Type 2 Management
Speaker: Shailini Singh, MD
4:50 PM - Q&A
5:30 PM - Closing Remarks
Speakers: Scott Sullivan, MD & Antonio Saad, MD
Parking
Parking is complimentary at the Inova Center for Personalized Health Conference Center (ICPH) . Use surface any surface lots. Use Entrance 3 under the pedestrian bridge to enter the Conference Center and take stairs or elevator to level 2.
Shuttle
Inova is offering a shuttle to and from both the Archer Hotel and Marriott to Inova Center for Personalized Health Conference Center.
Travel
Airports and Ground Transportation
Inova Center for Personalized Health Conference Center (ICPH) is centrally located between Washington Dulles Airport (IAD) and Reagan Airports (DCA). Union Station (in Washington, DC) is located about 30-40 minutes from the campus. Both airports along with Union Station offer onsite ground transportation to Fairfax, VA which is about a 30–40-minute drive. Uber or Lyft are also reliable ground transportation options in the DC metro area.
Hotels
Below are the two hotels that are located closest to the Inova Center for Personalized Health Conference Center (ICPH) and offer us discounted rates.
- Archer Hotel Falls Church - SOLD OUT the night of Wednesday, Nov. 5, 2025.
8296 Glass Alley, Fairfax, VA 22031
Phone: 571-327-2277
DPSG-NA Room Block Cut-Off Date is October 8, 2025
Archer Hotel Falls Church is nestled in the Mosaic - filled with shops, restaurants, and a Target.
Marriott Fairview Park - Book your room before Oct. 5th for the contracted room rate.
3111 Fairview Park Dr, Falls Church, VA 22042
(703) 849-9400
Marriott Fairview Park is slightly secluded and allows for quite and tranquil relaxing environment.
2025 Planning Committee
| Sarah D. Crimmins, DO Associate Professor Maternal Fetal Medicine Fellowship Director Division of Maternal Fetal Medicine Department of OBGYN University of Rochester Medical Center | Shad Deering, MD, CHSE, COL(ret), USA Medical Director, Inova Center for Advanced Medical Simulation Maternal Fetal Medicine Professor of Medical Education, University of Virginia |
| Audrey M Huang, MA, PhD Director, Science Communication and Science Editor Center for Advanced Research Training & Innovation (CARTI) Assistant Professor, Department of Obstetrics, Gynecology and Reproductive Sciences University of Maryland School of Medicine | Mark B. Landon MD Richard Meiling Professor and Chair Dept. of Obstetrics and Gynecology Ohio State University College of Medicine |
| Anna Palatnik, MD Patrick J. and Margaret G. McMahon Endowed Chair Associate Professor Vice Chair of Clinical Research Division of Maternal-Fetal Medicine Department of Obstetrics and Gynecology Medical College of Wisconsin | E. Albert Reece, MD, PhD, MBA Former Dean of Medicine & University Executive Vice President The Distinguished University and Endowed Professor & Director Center for Advanced Research Training and Innovation (CARTI); Senior Scientist, Center for Birth Defects Research University of Maryland School of Medicine |
| Karl Edward Seif, MD, FACOG Director, Diabetes in Pregnancy Program Assistant Professor University of Maryland School of Medicine Division of Maternal-Fetal Medicine Department of Obstetrics, Gynecology and Reproductive Sciences | Scott A Sullivan, MD, MSCR Director, Maternal-Fetal Medicine Inova Health Vice-Chair, Obstetrics IFH Professor, University of Virginia |
Speaker Disclosure Statement:
Inova Health System’s Office of Continuing Medical Education adheres to ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, program directors, and planners are required to disclose all relevant financial relationships with ineligible entities as defined by ACCME. All relevant financial relationships listed for these individuals have been mitigated.
Original Founders of DPSG-NA
E. Albert Reece, MD, PhD, MBA is an OB/GYN (Maternal-Fetal Medicine) internationally recognized physician-scientist, and scholar; former Dean of Medicine and University Executive Vice President at the University of Maryland School of Medicine (UMSOM). He has had a transformative 16-year leadership tenure at the University of Maryland (one of the longest serving Deans of Medicine in the US), where he has achieved great success particularly in research and clinical programs. As a result, the UMSOM is now in the top tier of research-intensive medical schools and ranked (US News and World Report) among the Top 10 public medical schools nationwide. He is currently the Distinguished University/Endowed Professor and director of CARTI, and senior scientist in the Center for Birth Defects Research at the UMSOM. He and his senior investigator colleague lead an NIH multimillion-dollar research laboratory group studying the bio-molecular mechanisms of diabetes-induced birth defects. They have identified and patented key molecular mechanistic intermediates. In addition, signaling pathways, oxidative and ER stress, epigenetics and premature aging are determined to be key contributors to the etiology. His scientific publications exceed 500 manuscripts, 12 books including revisions, and 5 monographs. As one of the Founders, of the Diabetes in Pregnancy Study Group of North America (DPSG-NA, he remains actively involved in conference programming, clinical and pre-clinical studies, and ensuring the study group’s longevity, scientific and clinical impact. |
E. Albert Reece, MD, PhD, MBA
Menachem Miodovnik was an enthusiastic and larger-than-life presence in maternal-fetal medicine. For nearly two decades, Miodovnik oversaw research funded by a National Institute of Child Health and Development program project grant at the University of Cincinnati Medical Center (UCMC) and the Cincinnati Children’s Hospital Medical Center (CCHMC) that showed that strict preconception glucose control could reduce reproductive failure, abortion, fetal malformations and maternal and neonatal morbidity, but many resulted in increased maternal hypoglycemia. His work resulted in hundreds of peer-reviewed publications on how to improve maternal and fetal outcomes for pregnancies complicated by diabetes. In addition to research, Miodovnik was a dedicated educator and mentor, who dedicated hundreds of hours as course director and instructor in local, regional, national and international conferences, also serving on a number of leadership and organizing committees. He was a keen proponent of bringing together professionals across fields, specialties, and disciplines to discuss and promote further research to improve the health and wellbeing of pregnant individuals with diabetes as broadly defined by type 1 diabetes, type 2 diabetes, gestational diabetes, and cardiometabolic health risk factors, and their offspring. He has been recognized by the American Academy of Family Physicians, the American College of Nutrition, the National Perinatal Association, the American Association of Birth Centers, and the organization he helped found, the Diabetes in Pregnancy Study Group of North America. We are deeply saddened by the passing of Dr. Menachem Miodovnik, a distinguished physician, researcher, and mentor. His dedication, expertise, and passion shaped our field and strengthened the DPSG-NA. Even in retirement, he remained a guiding force for young investigators and colleagues. To honor his legacy, donations will support a lectureship recognizing the DPSG-NA’s founding members. His impact on patient care, research, and mentorship will endure. |
Menachem Miodovnik (1946-2025)
Oded Langer was and continues to be internationally recognized for his outstanding contributions to the field of diabetes and pregnancy. He dedicated his 40-year career to promoting the translation of promising research findings into better clinical care for pregnant women and their children. His efforts to promote translational medicine include demonstrating that oral anti-hyperglycemic agents are safe and effective for managing diabetes in pregnancy; increasing our understanding the potential complications of diabetes for both mother and fetus; and helping to delineate the associations between levels of maternal hyperglycemia and adverse pregnancy outcomes. Dr. Langer contributed extensively to the literature in obstetrics, gynecology, and high-risk pregnancy through his extensive number of publications in both journals and textbooks. He was co-editor of four textbooks on diabetes and pregnancy and several journals focused on the topic. He also has served on a variety of journal editorial boards in this field. Dr. Langer was an invited presenter of the Norbert Freikel Lecture for the American Diabetes Association, named the prestigious Donnell D. Etzwiler Professorship, which is named after the late ADA president and former co-director of World Health Organization Collaborative Centers for Diabetes Education and Translation, recipient of the Andre Boivin Visiting Professorship at the Motherisk Program of the Hospital for Sick Children, Toronto. received the Award of Research Excellence from the Society of Maternal-Fetal Medicine on multiple occasions and was repeatedly recognized as “teacher of the year” for residents’ instruction at both Albert Einstein College of Medicine and the University of Texas Health Science Center at San Antonio, where he previously taught and conducted research. |
Oded Langer (1943-2019)
Speaker Disclosure Statement:
Inova Health System’s Office of Continuing Medical Education adheres to ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, program directors, and planners are required to disclose all relevant financial relationships with ineligible entities as defined by ACCME. All relevant financial relationships listed for these individuals have been mitigated.
Jacques Abramowicz, MD
Alfred Abuhamad
Huda Al-Kouatly, MD
Ashley Battarbee, MD, MSCR
Denise Bonds, MD, MPH
Katherine Bowers, PhD, MPH
Ebony Carter, MD, MPH
Patrick Catalano, MD
Janine Austin Clayton, MD
JAVIER CONTRERAS, B.S. Biology, California State University, Bakersfield
Sarah Crimmins, DO
Shad Deering, MD, COL(ret), USA, CHSE
Aoife Egan, MB BCh BAO, PhD
Shelley Ehrlich, MD ScD MPH
Maisa Feghali, MD
Christine Field, MD, MPH
Katherine Grantz, MD, MS
Sina Haeri, MD, MHSA
Teri Hernandez, PhD, RN, FAAN
Christine Hockett, PhD
Teresa Janevic, PhD, MPH
Jane Khoury
Mark Landon, MD
Monica Longo, MD, PhD
Rana Malek, M.D.
ketrell mcwhorter, PhD, MBA
Louis Muglia, MD
Ellen Murrin, DO
Leslie Myatt, PhD, FRCOG
Stephanie Olivier-Van Stichelen, PhD
Anna Palatnik, MD
Camille Powe, MD
Gladys Ramos, MD
E. Albert Reece, MD, PhD, MBA
Barak Rosenn, MD
Sourav Roy Choudhury, Sourav Roy Choudhury, Ph.D
Antonio Saad, MD FACOG FCCM MBA
George Saade, MD
Yoel Sadovsky, MD
Karl Seif, MD
Shailini Singh, MD
Scott Sullivan, MD
Shifa Turan, MD, RDMS
Amy Valent
Kartik Venkatesh, MD PhD, FACOG
Michael Warren
Cuilin Zhang, MD, PhD, MPH
Sarah Crimmins, DO
Audrey Huang, MD
Anna Palatnik, MD
E. Albert Reece, MD, PhD, MBA
Karl Seif, MD
Scott Sullivan, MD
Kartik Venkatesh, MD PhD, FACOG
Inova CME Accreditation
The Medical Society of Virginia is a member of the Southern States CME Collaborative, an ACCME Recognized Accreditor. Inova Health System Office of Continuing Medical Education is accredited by the Southern States CME Collaborative to provide continuing medical education for physicians.
Credit Designation
The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 16 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 16 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency and Assessment Form required for renewal of an active medical license in Virginia.
ABS CC Statement
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Nurse Credentialing FAQs
For the purpose of recertification, the American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For more information visit, https://www.nursingworld.org/certification/faqs/
Available Credit
- 16.00 ABS MOC
- 16.00 AMA PRA Category 1 Credit™
Thank you Exhibitors! Our event would not be possible without the generous support from our sponsors.
- Alexion, AZ Rare Disease
- Hologic Perinatal Specialist
- LilyLink
- Pfizer
- Samsung Ultrasound
Exhibitor Fee Summary
General Package: $3,000
(Nonprofit Package - same as General Package $250 (must submit 501c3))
- 6' undraped display table with two chairs
- Full access to conference sessions and meals for two exhibit representatives
- Verbal and name recognition the day of the conference with signage, podium mention and on screen during the conference
- Company name recognition on:
- Marketing emails
- Introduction slides, break slides, and closing slides
- Post-event follow-up attendee email
- Exhibitor page on event website
- Post attendee registration list (for those that opt in)
Premium Package: $3,500
- Prime table location, including a 6' undraped display table with three chairs
- Full access to conference sessions and meals for three exhibit representatives
- Verbal and name recognition the day of the conference with signage, podium mention and on screen during the conference
- Company name recognition on:
- Marketing emails
- Introduction slides, break slides, and closing slides
- Post-event follow-up attendee email
- Exhibitor page on event website
- Post attendee registration list (for those that opt in)
- Highlighted Website Listing:
- Your company’s sales contact information will be prominently displayed on the event website. This listing will feature, company name & sales contact person email address
Exclusive Bonus Exposure!
For just $1,000 more per package, take advantage of a unique opportunity as our event overlaps with the Ziai Pediatric & Family Medicine Conference on Nov. 7–8. Gain an extra half-day of direct access to 100+ Pediatricians, Family Medicine Physicians, RNs, NPs, Allied Health, and industry professionals!
Catering Sponsor Add-ons (Optional): Includes company name on buffet table signage
- Breakfast per day: $1,000
- Lunch per day: $1,500
- One Day's Break: $500
Ready to Register as an Exhibitor? CLICK HERE to be directed to the exhibitor registration site!
Questions? Email Christina Fontana for more information.
Price
Registration Information
In order to view all the event information, please sign in or create an account.
Ticket Types:
- Physician (MD/DO) - $450
- Advanced Practice Providers (APPs, NP, PA) - $350
- Registered Nurses (RN) - $300
- Physical Therapists (PT, PTA) - $250
- Other Healthcare Professionals - $200
- Non-Inova & Non-Inova Affiliates Residents and Fellows - $50
- Inova & Inova Affiliate Resident and Fellow - Comp
- Medical Students - Comp
Are you an Inova Employee?
You can register via cost center.
Once receiving approval from your department leader, enter your cost center into the ‘coupon’ field while registering (or checking out). If it doesn’t apply, please email [email protected] for additional assistance. Your sponsoring department will be charged the cost of registration after the event.
Photos
By registering you are agreeing to the possibility of having your picture taken by an Inova approved photographer and used in future marketing and advertising for the DPSG-NA event only.
Refunds
Refunds will be allowed up a to week before the event, May 23, 2025. Refund requests need to be submitted in writing to [email protected].